MedTrace Logo

Imaginal Exposure II Study: In-Vivo

NCT03934697 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2024-03-05

No results posted yet for this study

Summary

The purpose of this study is to test if imaginal exposure therapy can decrease symptoms of eating disorders and anxiety.

Conditions

  • Eating Disorder
  • Anorexia Nervosa
  • Bulimia Nervosa
  • Exposure

Interventions

BEHAVIORAL

imaginal exposure therapy

All participants will complete the same arm, which is ten sessions of imaginal exposure across a ten week time period. Each session is separated by 1 week.

Sponsors & Collaborators

  • University of Louisville

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2020-12-13
Completion
2022-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03934697 on ClinicalTrials.gov